Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs

Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs

US Patent 12433954 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Uses of amphiphiles in immune cell therapy and compositions therefor2025
Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof2025
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof2025
Anti-CD19 antibodies and multi-specific binding proteins2025
Delivery of biomolecules to immune cells2025
Multi-specific binding proteins and methods of use thereof2025
Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy2025
Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy2025
Immunostimulatory compositions and methods of use thereof2025
Combination immunotherapy for treatment of melanoma, colon or non-small cell lun2025